Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2003
12/04/2003CA2486716A1 Compositions and their uses for alleviating pain
12/04/2003CA2486709A1 Adduct of topiramate and tramadol hydrochloride and uses thereof
12/04/2003CA2486621A1 Induction and maintenance of tolerance to composite tissue allografts
12/04/2003CA2486620A1 Chimeric allograft tolerance induction, monitoring and maintenance
12/04/2003CA2486113A1 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
12/04/2003CA2485984A1 Pharmaceutical combination of pde5 inhibitors with ace inhibitors
12/04/2003CA2485972A1 Method for the use of pyranoindole derivatives to treat infection with hepatitis c virus
12/04/2003CA2485825A1 Method for identification of a ligand whereby receptor residence time is measured
12/04/2003CA2485184A1 Methods for the identification of ikkalpha function and other genes useful for treatment of inflammatory diseases
12/04/2003CA2485182A1 Plant thymidine kinases and their use
12/04/2003CA2484656A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
12/04/2003CA2483627A1 Mitotic kinesin inhibitors
12/03/2003EP1367123A1 Neurotonin and use thereof
12/03/2003EP1366772A1 Gm-csf and/or defensin protein expression regulators in epithelial cells comprising ets transcription factor or gene encoding the same
12/03/2003EP1366768A1 Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone
12/03/2003EP1366758A1 Novel ophthalmic compositions
12/03/2003EP1366180A2 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease
12/03/2003EP1366173A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
12/03/2003EP1366165A2 G-protein coupled receptors
12/03/2003EP1366164A1 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals
12/03/2003EP1366161A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof
12/03/2003EP1366158A2 Trp8, trp9 and trp10, markers for cancer
12/03/2003EP1366156A2 Osteolevin gene polymorphisms
12/03/2003EP1366152A2 G-protein coupled receptors
12/03/2003EP1366079A2 Nuclear hormone receptor ligand binding domain
12/03/2003EP1366077A2 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
12/03/2003EP1366059A2 Methods and compositions for modulating gluconeogenesis using pgc-1
12/03/2003EP1366055A2 Antiviral agents for treatment of flaviviridae infections
12/03/2003EP1366039A1 Piperazinylcarbonylquinolines and -isoquinolines
12/03/2003EP1366012A2 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
12/03/2003EP1365841A1 Essential n-3 fatty acids in cardiac insufficiency and heart failure therapy
12/03/2003EP1365812A2 Pharmaceutical composition having reduced tendency for drug crystallization
12/03/2003EP1365811A2 Compositions containing alpha-2-adrenergic agonist components
12/03/2003EP1365809A2 Methods for reducing chronic stress in mammals
12/03/2003EP1365808A2 Compositions for antitumour treatment containing ecteinascidin 743
12/03/2003EP1365806A2 Use of no acttivators for treatment and prevention of gastrointestinal disorders
12/03/2003EP1365798A2 Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
12/03/2003EP1365784A1 Methods and devices for tissue repair
12/03/2003EP1365781A1 Acrochordon alleviation
12/03/2003EP1365780A2 Immune response potentiation
12/03/2003EP1365779A1 Pharmaceutical or dietary composition containing a vegetable oil, in particular olive oil, and sitosterol
12/03/2003EP1365778A2 Treating pulmonary disorders with gaseous agent causing repletion of gsno
12/03/2003EP1365777A2 Proteoglycan compositions for treatment of inflammatory conditions
12/03/2003EP1365776A2 Use of an adenosine a3 receptor agonist for inhibition of viral replication
12/03/2003EP1365774A2 Use of zwitterionic polysaccharides for the specific modulation of immune processes
12/03/2003EP1365768A2 Use of erss-selective ligands for regulating fertility and compounds useful therefore
12/03/2003EP1365767A2 Pharmaceutical formulation comprising r-salmeterol and fluticasone propionate
12/03/2003EP1365766A2 Pharmaceutical composition for treatment of phimosis using topical corticosteroid
12/03/2003EP1365763A1 Farnesyl protein transferase inhibitor combinations with antiestrogen agents
12/03/2003EP1365761A1 Therapeutic combination of amlodipine and benazepril
12/03/2003EP1365759A2 Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
12/03/2003EP1365755A2 Use of pyrimidine nucleosides and/or the prodrugs thereof for combating the side-effects of haart (highly active anti-retroviral therapy) and other anti-viral therapies
12/03/2003EP1365753A2 Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer
12/03/2003EP1365749A2 Process for preparing pharmaceutical compositions for use with soft gelatin formulations
12/03/2003EP1365740A1 Rapid-onset medicament for the treatment of sexual dysfunction
12/03/2003EP1365739A1 Composition for rectal delivery of an oxazolidinone antibacterial drug
12/03/2003EP1365737A2 Stable salts of o-acetylsalicyclic with basic amino acids
12/03/2003EP1365684A2 Methods and devices for quantitative analysis of x-ray images
12/03/2003EP1365645A2 Transgenic mice containing targeted gene disruptions
12/03/2003EP1246634B1 Neurotoxins for treating pancreatic disorders
12/03/2003EP1165184B1 Estrogen receptor-beta antagonism and bone diseases
12/03/2003EP1140050B1 A composition useful to treat periodontal disease
12/03/2003EP1119557B1 Indeno-, naphto- and benzocyclohepta dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
12/03/2003EP1045709B1 Method and device for in-situ formulation of a medicinal solution for parenteral application
12/03/2003EP0758233B1 Pde iv inhibitors for treating multiple sclerosis
12/03/2003CN1460109A Improved specificity in treatment of diseases
12/03/2003CN1460105A 黄嘌呤磷酸二酯酶v抑制剂 Xanthine phosphodiesterase inhibitor v
12/03/2003CN1460100A Compounds and compositions for delivering active agents
12/03/2003CN1460026A Compositions containing alpha-2-adrenergic agonist components
12/03/2003CN1460023A Polymer-modified bioactive sythetic chemokines, and method for their mfg. and use
12/03/2003CN1460013A 局部凝胶给药体系 Topical gel delivery system
12/03/2003CN1459283A Usage of basic bismuth gallate for preventing and/or lowering degradation of skin
12/03/2003CN1129431C Combination of benzocyclobeptapyridine compounds and antineoplastic drugs for treating proliferative diseases
12/03/2003CN1129425C Medicated tissue paper product
12/02/2003US6657104 Cell-based, and whole-animal-based assays for detecting substances having therapeutic activity toward cardiac hypertrophy.
12/02/2003US6657047 Nucleotide sequences coding polypeptide for use in the treatment of tumors, inflammation, psoriasis, rheumatoid arthritis, cardiovascular and vision disorders
12/02/2003US6656973 Anticancer chemotherapy, and cytoprotective agents administered before, during or after chemotherapy to protect the normal cells of the patient
12/02/2003US6656971 Non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilins; inhibiting their peptidyl-prolyl isomerase activity; treating variety of medical conditions
12/02/2003US6656966 Nitrosated and nitrosylated taxanes, compositions and methods of use
12/02/2003US6656963 Indole-3-carbinol (I3C) derivatives and methods
12/02/2003US6656961 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
12/02/2003US6656960 Administering drug to produce cardiac asystole upon stimulation of one or both vagus nerves; inserting an electrode into esophagus of patient; actuating electrode to create an electrical field effective to stimulate vagus nerve
12/02/2003US6656955 Side effect reduction; synergistic mixture
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003US6656945 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-one cGMP-PDE inhibitors for the treatment of erectile dysfunction
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
12/02/2003US6656925 Mixture of nitric oxide inhibitor and aminosugar
12/02/2003US6656907 Method of treating gastric ulcer by administration of epidermal growth factor
12/02/2003US6656904 Inhibitors of proteasomal activity for stimulating bone and hair growth
12/02/2003US6656503 Counters ulcerogenic side effects; nonsteroidal antiinflam-matory core with polymer and misoprostol coating
12/02/2003US6656481 Vaccinal preparations
12/02/2003US6656475 Modulating growth of muscle or adipose tissue in eukaryotic organism using agent that affects myostatin signal transduction
12/02/2003US6656474 Minimal adverse side effects
12/02/2003US6656471 Monitoring HLA-Cw7-restricted CTL response; AIDS prevention
12/02/2003US6656464 Gastric emptying-promoting composition
12/02/2003US6656452 Use of inhaled NO as anti-inflammatory agent
11/2003
11/27/2003WO2003098223A2 A method for killing cells by inhibiting histone activity in the cell
11/27/2003WO2003097879A2 Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc
11/27/2003WO2003097871A2 Marker molecules associated with lung tumors
11/27/2003WO2003097852A2 Assay for identifying inhibitors of fc gamma riii signaling
1 ... 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 ... 1151